E, S., F. S, S. N, and F. M,
"Comparison on Efficacy and Safety of Three Inpatient Insulin Regimens for Management of non-critical Patients with Type 2 Diabetes",
Pharmacology and Pharmacy, vol. 4, issue 7, pp. 556-565, 2013.
E, A., S. A, Anis SE, Salem AB, Hu P, and D. Y.,
"Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on opticalmicroscopy and digital quantitative",
Diagnostic Pathology, vol. 13, issue 63, pp. 1-9, 2018.
E, M., A. A, N. M, and Z. Z,
"Value of Microwave Ablation in Treatment of large lesions of Hepatocellular Carcinoma",
journal of digestive disease, vol. 16, issue 8, pp. 456-463, 2015.
E, A.,
"Sinonasal Schneiderian papilloma (SP): A P53 Histochemical study and its correlation with histopathology",
Egypt. J. Ottolaryngol, vol. 22, No.2, June, issue No.2, June, pp. 151-166 , 2005.
kandeel e, E. N, H. M, S. M, and kamel A,
"Tracing Leukemia Stem Cells and Their Influence on Clinical Course of Adult Acute Myeloid Leukemia",
Clin Lymphoma Myeloma Leuk, vol. Jun;2020, issue 6, pp. 383-393, 2020.
E, N., Hassan N, E. - G. EA, H. H, A. MS, R. TV, K. L, G. B, I. SA, and G. M,
" Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes",
Cancers (Basel), vol. 13, issue 10, pp. 2318, 2021.
E, M., B. N, and M. M,
"Environmental and occupational lead exposure among children in Cairo, Egypt: A community-based cross-sectional study. Medicine.",
Medicine, vol. 95, issue 9, pp. e2976, 2016.
E, H., G. T, Khoweiled A, S. AE, A. D, M. R, F. H, and L. N,
"Lifetime prevalence of alcohol and substance use in Egypt: a community survey.",
Subst Abus., vol. 34, issue 2, pp. 97-104, 2013.
AbstractThe aim of this study was to determine the prevalence of substance use and addiction in Egypt and study its sociodemographic correlates.
METHOD:
A total of 44,000 subjects were interviewed from 8 governorates by stratified sampling. A questionnaire derived from the Addiction Severity Index (ASI) was individually administered.
RESULTS:
The lifetime prevalence of any substance use varies between 7.25% and 14.5%. One-month prevalence varies between 5.4% and 11.5% when adjusted to different population parameters. A total of 4832 subjects were identified as using illicit substances at least once in their life (9.6%), including 1329 experimental and social use (3.3%), 1860 regular use (4.64%), and 629 substance dependence (1.6%). The prevalence of substance use in males is 13.2% and 1.1% in females. Prevalence increases significantly in males of Bedouin origin, in seaside governorates, with lesser levels of education, and in certain occupations. The 15-19 age group showed the highest onset of substance use. Cannabis is the drug mostly misused in Egypt; alcohol is a distant second.
CONCLUSIONS:
The prevalence of substance use is lower than Western countries and higher compared with a 1996 survey. The true population prevalence is probably higher due to underreporting. The demographic pattern reflects availability and accessibility to drugs.
E, A., F. I, P. D, and S. S.,
"Triple negative, basal cell type and EGFR positive invasive breast carcinoma in Kuwaiti and British patients",
Breast J., vol. 2009 Jan-Feb, issue Jan-Feb;15(1), pp. 109-111, 2009.
E, M., S. H, F. H, and Z. Z,
"Evaluation of IL-10 and IL-12B Gene Polymorphisms on the Response The Standard of Care Therapy in Chronic Hepatitis C Patients: An Egyptian study",
BJMMr, vol. 4, issue 31, pp. 5015032, 2014.
]